Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

BUY
$0.29 - $0.63 $149 - $325
517 Added 0.56%
93,025 $27,000
Q4 2023

Feb 08, 2024

BUY
$0.22 - $0.53 $776 - $1,871
3,531 Added 3.97%
92,508 $34,000
Q3 2023

Nov 09, 2023

BUY
$0.59 - $2.04 $3,449 - $11,927
5,847 Added 7.03%
88,977 $52,000
Q2 2023

Aug 08, 2023

BUY
$1.77 - $2.38 $23,758 - $31,946
13,423 Added 19.26%
83,130 $152,000
Q1 2023

May 11, 2023

BUY
$1.5 - $3.5 $3,058 - $7,136
2,039 Added 3.01%
69,707 $158,000
Q4 2022

Feb 14, 2023

BUY
$1.77 - $3.9 $2,424 - $5,343
1,370 Added 2.07%
67,668 $137,000
Q3 2022

Nov 10, 2022

BUY
$0.57 - $4.74 $2,545 - $21,168
4,466 Added 7.22%
66,298 $222,000
Q2 2022

Aug 11, 2022

BUY
$2.94 - $5.12 $181,786 - $316,579
61,832 New
61,832 $182,000

Others Institutions Holding RBOT

About Vicarious Surgical Inc.


  • Ticker RBOT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 102,592,000
  • Market Cap $1.32B
  • Description
  • Vicarious Surgical Inc. engages in developing and selling single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. It offers Vicarious System, a single-incision surgical robot for ventral hernia repair. The company was incorporated in 2014 and is headquartered in Waltham, Massach...
More about RBOT
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.